SERA Prognostics CEO Lindgardt Zhenya sold 7,022 shares at $2 per share on 2026-09-10. The transaction left Zhenya with 837,848 shares and represented about 0.8% of the prior holding, giving investors the disclosed scale of the insider transaction.
Key Highlights
- Lindgardt Zhenya retained 837,848 SERA Prognostics shares after the transaction.
- The sale represented about 0.8% of the CEO’s prior shareholding.
- The filing reported transaction code S for the transaction.
SERA PROGNOSTICS, INC. (NASDAQ: SERA) Chief Executive Officer Lindgardt Zhenya sold 7,022 shares at $2 per share on 10 September 2026. The transaction was classified under code S.
CEO Retains 837,848 Shares Following the transaction, Zhenya owned 837,848 shares.
The filing reports transaction code S for the transaction. The disclosed price was $2 per share.
Sale Covered About 0.8%
of Prior Holding The transaction represented about 0.8% of Zhenya’s prior shares holding in SERA PROGNOSTICS, INC. Transaction code S denotes an open-market or private sale.
FAQs
Q: How many SERA Prognostics shares did Lindgardt Zhenya sell?
A: The filing reports that SERA Prognostics CEO Lindgardt Zhenya sold 7,022 shares at $2 per share on 10 September 2026. It identifies the transaction in a Form 4 filing.
Q: What was the impact of the SERA Prognostics insider sale?
A: Following the transaction, Lindgardt Zhenya owned 837,848 SERA Prognostics shares. The filing states that the transaction represented about 0.8% of Zhenya’s prior shareholding.
Q: Was the SERA Prognostics CEO transaction an open-market sale?
A: The filing reports transaction code S for Lindgardt Zhenya’s 7,022-share sale at $2 per share. It does not state that the transaction was an open-market sale.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.